GlassScriptPhysician profile
Mily Nieves
NPI 1508901612
$11,734.17
in general payments reported to CMS, 2019-2025
18 companies · $475 in 2025
The $475 reported for 2025 was more than what 79% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $316 · 2020: $167 · 2021: $83.01 · 2022: $100 · 2023: $7,903 · 2024: $2,690 · 2025: $475.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $8,500 · Travel and Lodging: $1,437 · Food and Beverage: $1,131.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $8,500.00 |
| Travel and Lodging | $1,437.21 |
| Food and Beverage | $1,131.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $10,151.96 | 2023-2024 | Davinci Xi, Da Vinci Surgical System |
| Hologic Sales and Service, LLC | $512.99 | 2019-2025 | Sonata Sonography-Guided Transcervical Fibroid Ablation System, Acessa Provu System, Affirm Prone Biopsy System |
| Organon LLC | $269.47 | 2024 | |
| Abbvie INC. | $123.22 | 2019 | |
| Channel Medsystems, INC. | $120.60 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $98.02 | 2019-2023 | |
| Astellas Pharma US INC | $89.91 | 2023-2025 | Veozah |
| Roche Diagnostics Corporation | $79.14 | 2019 | |
| Coopersurgical, INC. | $58.55 | 2025 | Paragard T 380a |
| Biogen, INC. | $57.17 | 2025 | Zurzuvae |
| Optumhealth Care Solutions, LLC | $49.88 | 2024-2025 | Eitan Medical, Vivify Health Care Team Portal 001 |
| Ethicon US, LLC | $36.82 | 2023 | Harmonic, Ethicon, Stratafix |
| Therapeuticsmd, INC. | $18.12 | 2022 | |
| Minerva Surgical, INC | $16.91 | 2019 | |
| Amag Pharmaceuticals, INC. | $16.16 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $12.17 | 2019 | |
| Mylan Pharmaceuticals INC. | $12.07 | 2020 | |
| Daiichi Sankyo INC. | $11.01 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mily Nieves listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.